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It has been demonstrated that reprogramming
factors are sequestered in the pronuclei of zygotes
after fertilization, because zygotes enucleated at
the M phase instead of interphase of the first mitosis
can support the development of cloned embryos.
However, the contribution of the parental pronucleus
derived from either the sperm or the oocyte in
reprogramming remains elusive. Here, we demon-
strate that the parental pronuclei have asymmetric
reprogramming capacities and that the reprogram-
ming factors reside predominantly in themale pronu-
cleus. As a result, only female pronucleus-depleted
(FPD) mouse zygotes can reprogram somatic cells
to a pluripotent state and support the full-term
development of cloned embryos; male pronucleus-
depleted (MPD) zygotes fail to support somatic cell
reprogramming. We further demonstrate that fusion
of an additional male pronucleus into a zygote greatly
enhances reprogramming efficiency. Our data pro-
vide a clue to further identify critical reprogramming
factors in the male pronucleus.INTRODUCTION
Somatic cell nuclear transfer (SCNT) experiments have revealed
that molecules within oocytes at the metaphase II stage can
reprogram somatic cells (Kato et al., 1998; Wakayama et al.,
1998; Wilmut et al., 1997). Following fertilization, the reprogram-
ming factors are believed to translocate from the cytoplasm into
the pronuclei of zygotes, as zygotes that are enucleated at M
phase instead of interphase retain the ability to reprogram
somatic cells (Egli et al., 2007).
During fertilization, the parental genomes undergo differential
epigenetic reprogramming to form a totipotent zygote. Immedi-
ately after fertilization, protamine is quickly released from the
paternal genome and the decondensed sperm DNA is repack-
aged by maternal nucleosomal histones (McLay and Clarke,
2003). The active histone methylation marker H3K4me3 can1008 Cell Reports 6, 1008–1016, March 27, 2014 ª2014 The Authorsbe detected in the male pronucleus, but repressive histone
methylation markers, including H3K9me2-3, H3K27me3, and
H4K20me3, are mostly absent (Lepikhov et al., 2010). In
contrast, all of these histone methylation markers can be
detected in the female pronucleus. In addition to histone modifi-
cations, it is widely known that the paternal genome undergoes
genome-wide DNA demethylation around the PN3 stage,
whereas the DNA methylation state of the maternal genome
seems to maintain a constant level (Mayer et al., 2000; Wossidlo
et al., 2010).
Although the epigenetic modifications appear to differ
between the male and female pronucleus, it remains unknown
whether the parental pronuclei play distinct roles in reprogram-
ming of somatic cells. In the present study, we designed serial
nuclear transplantation experiments to address whether the
parental pronuclei contribute equally to reprogramming. Inter-
estingly, we found that the reprogramming factors seem to
sequester asymmetrically in the parental pronuclei and the
critical reprogramming factors reside predominantly in the
male pronucleus. As a result, cloned offspring and nuclear trans-
fer embryonic stem cell (ntESC) lines could only be generated
from female pronucleus-depleted (FPD) zygotes, and male pro-
nucleus-depleted (MPD) zygotes failed to support somatic cell
reprogramming. We further demonstrated that the distinct
epigenetic modifications of parental pronuclei might contribute
directly to the developmental differences observed among
somatic cell cloned embryos. More importantly, we found that
fusion of an extra male pronucleus can significantly increase
the efficiency of zygotic reprogramming, which may be informa-
tive for deriving human ntESC lines by using clinically discarded
multipronuclei zygotes.RESULTS
FPD Zygotes Enucleated in Mitosis Can Support
Full-Term Development of ESC Cloned Embryos
To determine the reprogramming capacity of the parental pronu-
cleus, we used FPD orMPD zygotes that had been enucleated at
M phase as the recipient cytoplasm. Zygotes that had been
enucleated at M phase or interphase were used as positive
and negative controls, respectively (Figure 1A). As shown in Fig-
ure 1B, the female andmale pronuclei of themouse zygote could
be clearly distinguished based on their distance from the second
polar body and their distinct size (Adenot et al., 1997). Immuno-
cytochemistry staining of 5-hydroxymethylcytosine (5hmC) and
5mC further confirmed this observation (Figure 1E) (Gu et al.,
2011; Wossidlo et al., 2010). The removal of either pronucleus
was performed by piezo-drill-assisted micromanipulation and
was further confirmed by 5mC and 5hmC staining (Figures 1C–
1G). The preimplantation developmental efficiency of the resul-
tant haploid androgenetic or gynogenetic embryos was similar
to previously reported results (Table S1) (Modlinski, 1975;
Yang et al., 2012).
FPD zygotes, MPD zygotes, and control intact zygotes were
cultured in embryo culture medium containing demecolcine
(DC) to prevent the progression of mitosis and to limit spindle
formation at metaphase (Gasparrini et al., 2003). After themitotic
zygotes were released from DC exposure, they were transferred
to medium containing MG-132, a proteasome inhibitor, for
25 min to allow assembly of the mitotic spindle (Riaz et al.,
2011), which can be visualized by light microscopy (Figure 1H).
Subsequently, the spindle was removed by micromanipulation,
and staining with the DNA dye Hoechst 33342 confirmed the
successful removal of chromosomes (Figure 1I). To compare
the developmental potential of cloned embryos reconstituted
with the different recipient cytoplasts, we used both OG2
(Oct4-GFP transgenic) ESCs (Figure S1A) andmouse embryonic
fibroblasts (MEFs) arrested at M phase as donor cells for
chromosome transfer experiments. The M-phase spindle-
chromosome complexes were then microinjected into the
aforementioned recipient cytoplasts to reconstitute cloned
embryos (Figure 1J). After chromosome transfer and release
from MG-132 exposure, segregation of the chromosomes and
cytokinesis of the cloned embryos were observed within 2 hr
(Figure 1K).
When ESCs were used as donors, 58 of 64 cloned embryos
reconstructed using a zygote enucleated at M phase of mitosis
cleaved, and 53% of the cleaved embryos developed to the
blastocyst stage (Figure 1N), which is consistent with a previous
report (Egli et al., 2007). When FPD zygotes were used for
ESC chromosome transfer, 16% of the cloned embryos
developed to the blastocyst stage. Albeit with low efficiency,
10% of the cloned embryos reconstructed using MPD
zygotes developed to the blastocyst stage (Figures 1L–1N).
When cloned embryos developed to the 4-cell stage, the
differences between the FPD and MPD groups were significant
(52% versus 30%) (Figure 1N). Serving as the negative control,
nuclear transfer into zygotes at interphase led to development
failure (Figure 1N).
We next evaluated the in vivo developmental potential of
ESC cloned embryos reconstructed using either FPD or MPD
zygotes by transferring 2-cell-stage cloned embryos into the
oviducts of pseudo-pregnant females (Figures 2A and S1B).
We evaluated the embryonic development of these cloned em-
bryos, which were reconstituted using two different recipient
cytoplasts, at embryonic day 10.5 (E10.5) and E14.5 and at
full-term development, E19.5 (Table S2). One E10.5 embryo
and one E14.5 embryo were recovered from the 215 transferred
OG2-ESC cloned embryos reconstructed using FPD zygotes
by cesarean section (Figures S1D–S1G). Oct4-GFP-positiveCecells could be visualized in the gonads of the E10.5 and
E14.5 cloned embryos (Figures S1D and S1F). In contrast, no
OG2-ESC cloned embryos reconstructed using MPD zygotes
developed to the E10.5 stage (Figure S1C). Next, we used
CMV-GFP ESCs as donor cells for chromosome transfer to
easily observe cell origin. For this purpose, 2-cell-stage cloned
embryos with GFP were produced and transferred to pseudo-
pregnant females (Figure 2B). Three living pups were success-
fully recovered by cesarean section at E19.5 from 561 CMV-
GFP ESC cloned embryos reconstructed using FPD zygotes
(Figures 2C and 2D). All three of the cloned pups exhibited
regular respiration, but one was killed because of a midline
closure defect and one was rejected by the foster mother.
One pup survived to adulthood and proceeded to produce F1
pups after mating with normal ICR mice (Figure 2C). The cloned
pup was GFP positive, and PCR analysis of polymorphic
markers verified that they were the same as those of the
ESCs (Figures 2D and 2E). Consistent with previous reports
(Eggan et al., 2001; Gao et al., 2003; Wakayama et al., 1999),
the placental weight of the ESC cloned pups was found to be
significantly higher than that of control placentas (Figure 2F).
In striking contrast, no cloned pups were obtained from the
308 transferred CMV-GFP ESC cloned embryos reconstructed
using MPD zygotes.
The experiments described thus far demonstrated that ESC
chromosomes can be successfully transferred into either FPD
or MPD zygotes to reconstruct cloned embryos. However, the
developmental potential of the ESC cloned embryos recon-
structed using FPD zygotes appeared to be better than that of
the cloned embryos reconstructed using MPD zygotes.
FPD Zygotes, but Not MPD Zygotes, Can Support
Preimplantation Development of Somatic Cloned
Embryos
We next sought to investigate whether and to what extent the
FPD or MPD zygotes could support somatic cell reprogram-
ming. OG2 MEFs were used as donor cells for chromosome
transfer, and reactivation of Oct4 in the cloned embryos served
as a hallmark of successful reprogramming (Figure 3A). We per-
formed 16 experiments using FPD zygotes (n = 1,030), and
consistently obtained somatic cloned blastocysts in 14 of
them. In contrast, a total of nine experiments using MPD zy-
gotes were performed, and no cloned blastocyst was obtained.
In addition, we also compared the percentages of 4-cell embryo
and morulae development between the FPD versus MPD
groups, and the difference appeared significant (40% versus
16%) (Figure 1N). Overall, our results demonstrated that only
somatic cell cloned embryos reconstructed using FPD zygotes
can develop to the blastocyst stage. Moreover, expression of
the Oct4-GFP transgene was observed only in the cloned em-
bryos reconstructed using FPD zygotes. Oct4-GFP expression
in the cloned embryos was detectable in late-cleavage-stage
embryos and was strong in cloned blastocysts (Figures 3B
and S2A–S2C), similar to previously reported results (Riaz
et al., 2011; Yoshimizu et al., 1999). We further demonstrated
that this asymmetric reprogramming capacity is likely not
caused by the size difference between the parental pronuclei,
because depletion of the male pronucleus at the earlier stagell Reports 6, 1008–1016, March 27, 2014 ª2014 The Authors 1009
Figure 1. Chromosome Transfer into FPD or MPD Zygotes Enucleated at M Phase of Mitosis
(A) Schematics of chromosome transfer into FPD or MPD zygotes. Following fertilization, factors that are required for reprogramming and development are
hypothesized to sequester equally or selectively in the male or female pronucleus. After removal of the female or male pronucleus at the PN3-PN4 stage,
(legend continued on next page)
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Figure 2. In Vivo Developmental Potential of
Cloned EmbryosReconstructed Using ESCs
(A) Diagram of ESC chromosome transfer into an
enucleated FPD zygote for mouse cloning.
(B) Two-cell-stage embryos reconstructed using
CMV-GFP ESCs. Green fluorescence indicates
that the CMV-GFP transgene has been expressed.
(C) A live cloned pup with an enlarged placenta,
and an adult cloned mouse with germline trans-
mission ability.
(D) The CMV-GFP ESC-cloned pup exhibits green
fluorescence, whereas the control does not.
(E) DNA genotyping of the cloned pups confirmed
their ESC origin.
(F) Body and placental weights of the cloned pups
at birth. Control pups were from untreated normal
embryos. DC, DC treatment 28–33 hr after human
chorionic gonadotropin (hCG) injection; MG, 2 mM
MG-132 treatment 33–33.5 hr after injection with
hCG. Data are mean ± SD.
See also Figure S1 and Table S2.(PN2), when no size difference was distinguished between
parental pronuclei, showed no beneficial effects on somatic
cell reprogramming (Table S3). In addition, we also evaluated
the postimplantation development of somatic cloned embryos
reconstructed with FPD zygotes. Unfortunately, no live cloned
mice were obtained, although some degenerated embryos
could be observed (Table S4).
Fully Pluripotent ESC Lines Established from Somatic
Cloned Embryos Reconstructed by Chromosome
Transfer into FPD Zygotes
To investigate whether chromosome transfer ESC (ctESC)
lines can be successfully established from somatic cloned
embryos reconstructed using FPD zygotes, we individuallymanipulated zygotes underwent nuclear envelope breakdown (NEBD) and entered mitosis. Mitotic donor cel
MPD zygotes to reconstitute cloned embryos.
(B) Mouse zygote with two pronuclei at interphase.
(C) FPD zygote in interphase.
(D) MPD zygote in interphase.
(E–G) Immunofluorescent staining of 5hmC (green) and 5mC (red) in a normal zygote (E), FPD zygote (F), andM
pronucleus, respectively. PB, polar body.
(H) FPD zygote at M phase in the presence of MG-132.
(I) The spindle was removed from the FPD zygote at M phase.
(J) ESC spindle-chromosome complex was injected into the enucleated FPD zygote.
(K) Chromosome segregation and cytokinesis occurred in the reconstructed embryo within 2 hr after transfe
(L and M) Blastocyst-stage cloned embryos reconstructed by ESC chromosome transfer into male-pronucl
(N) Developmental potency of cloned embryos reconstructed using ESCs or somatic cells. Zyg., zygote. _Zy
interphase. Data are mean ± SEM. The values with different superscript letters indicate significant differenc
compared separately (p < 0.05). *Blastocyst rate based on the number of blastocysts at E3.5.
See also Table S1.
Cell Reports 6, 1008–1016plated the cloned blastocysts in 96-well
plates. Four ctESC lines (referred to as
_M-1 to _M-4) expressing Oct4-GFP
were ultimately established from 24
cultured cloned blastocysts (Figure 3C).
As a control, one ctESC line exhibiting
pluripotency was established from thesomatic cloned embryo reconstructed using fibroblast chro-
mosome transfer into a zygote enucleated at M phase
(Figure S3).
The characteristics of these four ctESC lines were evaluated.
Karyotyping analysis revealed the presence of the normal 40
chromosomes in one female cell line and three male cell lines
(Figure 3D). The expression of pluripotent ESC markers, such
as Oct4, Sox2, Nanog, and SSEA1, was observed by staining
(Figure 3E). Bisulfite sequencing analysis indicated that suc-
cessful demethylation occurred in the promoters of Oct4 and
Nanog in the ctESC lines (Figure 3F). The global gene-expression
profile of the ctESC lines clustered closely with normal R1 ESCs
(Figure 3G). The in vivo differentiation potential of these
ctESC lines was also confirmed by a teratoma assay followingls were then transferred into the enucleated FPD or
PD zygote (G)._ and \ indicate themale and female
r.
eus-depleted zygotes.
g., FPD zygote. \Zyg., MPD zygote. M, M phase; I,
es in the same column. Different donor cells were
, March 27, 2014 ª2014 The Authors 1011
Figure 3. Derivation of ctESC Lines from Somatic Cell Chromosome Transfer-Derived Cloned Blastocysts
(A) Schematics of ctESC derivation from cloned embryos reconstructed by somatic cell chromosome transfer (SCCT) into enucleated FPD zygotes, and clonal
mice production through tetraploid complementation.
(B) Cloned blastocysts produced by SCCT into enucleated FPD zygotes.
(C) ctESC line produced from the cloned blastocysts.
(D) Karyotype of the ctESC line.
(E) Immunostaining of the pluripotent markers Oct4, Sox2, Nanog, and SSEA1. Scale bar, 20 mm.
(F) Methylation analysis of MEFs and ctESCs. Open and closed circles indicate unmethylated and methylated CpGs, respectively.
(G) Gene-expression analysis of ctESC lines, zygote-derived ESC lines, MEFs, and R1 cells.
(H) ctESCs possessed multiple-differentiation potential, as shown in teratoma sections.
(I) A female chimera and its germline offspring.
(J) Full-term all-ctESC (clonal) mice produced from the ctESC lines through tetraploid complementation. Green fluorescence indicates that both female (upper
row) and male (lower row) clonal mice carry the Oct4-GFP transgene, and the oocytes and seminiferous tubules are GFP positive.
(K) DNA genotyping of the clonal mice confirms their ctESC origin.
See also Figures S2–S4 and Tables S3–S6.injection into immunocompromised severe combined immuno-
deficiency (SCID) mice. Cell types representing all three germ
layers were observed (Figure 3H).1012 Cell Reports 6, 1008–1016, March 27, 2014 ª2014 The AuthorsAll four ctESC lines possessed a high degree of germline
chimerism, as judged by the green fluorescence of E13.5
chimeric embryos generated by injecting ctESCs into normal
blastocysts (Table S5). When allowed to develop to term, the
postnatal chimeric mice also displayed a high degree of agouti
coat-color chimerism and germline transmission (Figure 3I).
To further investigate the level of pluripotency of the ctESC
lines derived from the somatic cloned embryos reconstructed
using FPD zygotes, we performed tetraploid complementation,
the most stringent test of pluripotency. In total, 36 full-term
all-ctESC mice were obtained from three of the four ctESC
lines with high efficiency (Figure 3J; Table S6). Polymorphic
marker analysis using PCR verified that the all-ctESC mice
were indeed derived from the ctESC lines (Figure 3K). Further-
more, the all-ctESC mice exhibited Oct4-GFP transgene
expression in the germinal vesicle (GV) oocytes or seminiferous
tubules (Figure 3J). Moreover, the all-ctESC mice produced
using tetraploid complementation grew to adulthood and pro-
duced F1 pups after mating with normal ICR mice (Figures
S4A–S4C). Most importantly, the oocytes collected from
the female F1 mice exhibited Oct4-GFP positivity (Figures
S4D and S4E).
These results demonstrated that the FPD zygotes could
successfully reprogram somatic cells to full pluripotency. In
striking contrast, theMPD zygotes were incapable of reprogram-
ming somatic cells, which indicates that the parental pronuclei
have asymmetric reprogramming capacities.
Distinct Epigenetic Reprogramming Ability of Parental
Pronuclei in Somatic Cloned Embryos
To better understand the underlying mechanism of the reprog-
ramming asymmetry of the parental pronuclei, we analyzed the
major epigenetic modifications that occurred in the somatic
cloned embryos reconstructed with either the FPD or MPD
zygotes. Since most somatic cloned embryos reconstructed
using MPD zygotes were arrested at the 2-cell stage, we used
2-cell-stage cloned embryos for the analysis. The intensity of
H3K4me3 staining did not differ between the two types of cloned
embryos (Figures 4A and 4B). However, staining for H3K9 acet-
ylation, H3K9me3, 5hmC, and 5mC revealed dramatic differ-
ences between the two types of cloned embryos (Figures 4A
and 4B). The staining intensity of the gene-silencing markers
H3K9me3 and 5mC (Bui et al., 2008; Chen et al., 2013; Wang
et al., 2007; Wossidlo et al., 2010, 2011) in the cloned embryos
reconstructed using MPD zygotes was much higher than that
in the cloned embryos reconstructed using FPD zygotes. In
contrast, the staining intensity of the putative gene-activating
markers H3K9 acetylation and 5hmC (Lennartsson and Ekwall,
2009; Weinberger et al., 2012) in cloned embryos reconstructed
using MPD zygotes was significantly lower than that in the
cloned embryos reconstructed using FPD zygotes (Figures 4A
and 4B). Furthermore, bisulfite sequencing analysis indicated
that successful demethylation occurred in the promoter of
Oct4 in the 2-cell-stage cloned embryos reconstructed using
FPD zygotes. In contrast, the promoter of Oct4 remained highly
methylated in the 2-cell-stage cloned embryos reconstructed
using MPD zygotes (Figure 4C). Taken together, these results
indicate that the genes that are important for development might
not be properly activated in the cloned embryos reconstructed
using MPD zygotes, which would cause their developmental
arrest.CeFusion of an Extra Male Pronucleus into the Zygote Can
Significantly Improve the Zygotic Reprogramming
Ability
As noted above, although FPD zygotes can reprogram somatic
cells to a pluripotent state and produce full-term cloned
embryos, the cloned embryos still have a lower developmental
efficiency than those reconstructed with zygotes enucleated at
M phase. We therefore attempted to ask whether the develop-
mental potential of cloned embryos could be improved by
introducing an extra male pronucleus into the FPD zygotes or
normal zygotes. We obtained two-male-pronuclei zygotes
by fusing an extra male pronucleus with the FPD zygotes
(Figure 4D). The fusion of an extra male pronucleus with the
FPD zygotes significantly improved the reprogramming process.
The cloned embryos reconstructed using two-male-pronuclei
zygotes had a significantly higher blastocyst development
efficiency than the single-pronucleus zygotes (19% versus 4%;
Figure 4E). Most interestingly, the fusion of an extra male pro-
nucleus with mouse zygotes significantly increased the reprog-
ramming efficiency to a level even higher than that observed in
oocytes (Figures 4F and 4G; Table S7).
DISCUSSION
In summary, our present study clearly demonstrates that the
parental pronuclei of themouse zygote have asymmetric reprog-
ramming capacities. Our study indicates that the reprogramming
factors preferentially translocate into the male pronucleus
following fertilization, and thus provides a fundamental basis
for characterizing candidate reprogramming factors in the future.
Some well-studied factors might correlate with this reprogram-
ming asymmetry. It was previously shown that Parp1 is localized
mainly in the male pronucleus, and the overexpression of Parp1
can effectively promote induced pluripotent stem cell (iPSC)
induction (Chiou et al., 2013; Wossidlo et al., 2010). Moreover,
we found that Parp1 was localized mainly in the male pronucleus
at distinct pronuclear stages (PN1–PN5) and Parp1 dissociated
from chromatin during mitosis (Figure S4F). Similarly, DNA diox-
ygenase Tet3 localizes mainly in the male pronucleus following
fertilization, and oocytes lacking Tet3 have a reduced ability to
reprogram somatic cells (Gu et al., 2011). Furthermore,
H3K9me3 has been found to serve as a barrier during somatic
cell reprogramming into iPSCs (Chen et al., 2013), and in our ex-
periments, we noticed that the removal of somatic H3K9me3
could only be observed in cloned embryos reconstructed with
FPD zygotes.
The cytoplasm of an oocyte is evolutionally designed to repro-
gram the sperm. It is well accepted that the sperm is more differ-
entiated, as the paternal genome of mouse sperm contains
higher levels of genome-wide DNA methylation than the oocyte
(Smallwood et al., 2011), and therefore more reprogramming
factors are required. This might explain why the critical reprog-
ramming factors selectively translocate into themale pronucleus
during fertilization.
We recently demonstrated that ntESCs exhibit enhanced
telomere rejuvenation and improved mitochondrial function rela-
tive to iPSCs (Le et al., 2014). However, the cloning procedure
needs to be further optimized because the cloning efficiencyll Reports 6, 1008–1016, March 27, 2014 ª2014 The Authors 1013
(legend on next page)
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remains very low at present. One possible explanation for this
low efficiency is that the reprogramming factors within an oocyte
are insufficient for reprogramming a somatic cell, but attempts to
remedy this by adding additional cytoplasm showed no sig-
nificant effect (Sayaka et al., 2008). Given the fact that the
reprogramming capacity of zygotes is inferior to that of oocytes,
it is very important to search for a new approach to improve the
reprogramming capacity of zygotes. Our study demonstrates
that the fusion of an extra male pronucleus can dramatically
improve the reprogramming capacity of zygotes. It is informative
regarding the derivation of human ntESC lines using multi-
pronuclei zygotes instead of oocytes (Tachibana et al., 2013),
because multi-pronuclei zygotes are generally discarded in
human in vitro fertilization clinics, and the use of these discarded
embryos for the derivation of patient-specific ntESC lines no
longer poses ethical issues.EXPERIMENTAL PROCEDURES
Mice
All mice used in this study were housed in the animal facility of the National
Institute of Biological Sciences. Our study procedures were consistent with
the National Institute of Biological Sciences guidelines.
Chromosome Transfer
Chromosome transfer was conducted as previously described (Egli et al.,
2007). Female or male pronuclei were removed using a piezo-drill micromanip-
ulator. After treatment with DC and MG-132, the spindle-chromosome com-
plexes of the mitosis-arrested haploid zygotes were removed, and mitotic
donor cell chromosomes were then transferred into the enucleated zygotes.
The reconstructed embryos were cultured and allowed to develop to the
blastocyst stage.
Immunofluorescence Staining
ESCs and reconstructed and normal early embryos were stained according to
previously described protocols (Gao et al., 2013; Wang et al., 2007). Stained
cells were observed with an LSM 510 META microscope (Zeiss).
Microarray Analysis
Total RNA was extracted using Trizol reagent (Invitrogen) in two separate
experiments. Analysis with the Mouse Gene 1.0 ST array (Affymetrix) was
performed at CapitalBio in Beijing.ACCESSION NUMBERS
The microarray data have been deposited in the GEO database under acces-
sion number GSE49148.Figure 4. Fusion of an Extra Male Pronucleus into the Zygote Can Sign
(A) Immunofluorescence images of reconstructed 2-cell embryos after SCCT int
were stained for H3K4me3, H3K9ac, 5hmC/5mC, and H3K9me3. _SCCT, SCC
enucleated at M phase. Scale bar, 20 mm.
(B) Quantitative analysis of H3K4me3, H3K9ac, 5hmC, and H3K9me3 fluorescenc
the level of the green signal relative to the PI (5hmC relative to DAPI) staining int
(C) Bisulfite sequencing analysis of Oct4 demethylation in 2-cell-stage cloned em
and normal 2-cell-stage embryos were used as controls. IVC, in vitro cultured.
(D) Immunofluorescent staining of 5hmC (green) and 5mC (red) in a __zygote (__
(E) Developmental potency of cloned embryos reconstructed with or without an
(F and G) Developmental potency of cloned embryos reconstructed with a zygote
SEM. *p < 0.05; **p < 0.01.
See also Table S7.
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